CHUV
Les activités du CHUV
MENU
Centre du sein
Accueil > Recherche > Publications > Publications 2014

Publications 2014


1.

Decensi A, Sun Z, Guerrieri-Gonzaga A, Thürlimann B, McIntosh C, Tondini C, Monnier A, Campone M, Debled M, Schönenberger A, Zaman K, Johansson H, Price KN, Gelber RD, Goldhirsch A, Coates AS, Aebi S.
Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences.

Breast Cancer Res Treat. 2014 Feb 1. PubMed PMID:24487691.

2.

De Vries M, Stiefel F.
Psycho-oncological interventions and psychotherapy in the oncology setting.

Recent Results Cancer Res. 2014;197:121-35. doi: 10.1007/978-3-642-40187-9_9. PubMed PMID:24305773.

3.

Ludwig G, Krenz S, Zdrojewski C, Bot M, Rousselle I, Stagno D, Luethi F, Leyvraz S, Stiefel F.
Psychodynamic interventions in cancer care I: psychometric results of a randomized controlled trial.

Psychooncology. 2014 Jan;23(1):65-74. doi: 10.1002/pon.3374. Epub 2013 Aug 27. PubMed PMID:23983096.

4.

Krenz S, Godel C, Stagno D, Stiefel F, Ludwig G.
Psychodynamic interventions in cancer care II: a qualitative analysis of the therapists' reports.

Psychooncology. 2014 Jan;23(1):75-80. doi: 10.1002/pon.3373. Epub 2013 Aug 23. PubMed PMID:23970492.

5.

Stravodimou A, Zaman K, Voutsadakis IA

Vinorelbine with or without Trastuzumab in Metastatic Breast Cancer: A Retrospective Single Institution Series.

ISRN Oncol. 2014 Mar 30;2014:289836. doi: 10.1155/2014/289836. eCollection 2014.PMID: 25006504

6.

Orcurto A, Odermatt R, Stravodimou A, Wolfer A

Endocrine therapy resistance in metastatic breast cancer: mechanisms and clinical implications.

Rev Med Suisse. 2014 May21;10(431):1102-6. Review. French. PMID: 24941677

7.

MacGrogan G, Mathieu MC, Poulet B, Penault-Llorca F, Vincent-Salomon A, Roger P, Treilleux I, Valent A, Antoine M, Becette V, Bor C, Brabencova E, Charafe-Jauffret E, Chenard MP, Dauplat MM, Delrée P, Devouassoux M, Fiche M, Fondrevelle ME, Fridman V, Garbar C, Genin P, Ghnassia JP, Haudebourg J, Laberge-Le Couteulx S, Loussouarn D, Maran-Gonzalez A, Marcy M, Michenet P, Sagan C, Trassard M, Verriele V, Arnould L, Lacroix-Triki M; GEFPICS.

Pre-analytical stage for biomarker assessment in breast cancer: 2014 update of the GEFPICS' guidelines in France.

Ann Pathol. 2014 Oct;34(5):366-72. doi: 10.1016/j.annpat.2014.08.017. Epub 2014 Sep 26. French. PMID: 25439989

8.

Penault-Llorca F, Vincent-Salomon A, MacGrogan G, Roger P, Treilleux I, Valent A, Mathieu MC, Antoine M, Becette V, Bor C, Brabencova E, Charafe-Jauffret E, Chenard MP, Dauplat MM, Delrée P, Devouassoux M, Fiche M, Fondrevelle ME, Fridman V, Garbar C, Genin P, Ghnassia JP, Haudebourg J, Laberge-Le Couteulx S, Loussouarn D, Maran-Gonzalez A, Marcy M, Michenet P, Poulet B, Sagan C, Trassard M, Verriele V, Arnould L, Lacroix-Triki M; GEFPICS.

2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France.

Ann Pathol. 2014 Oct;34(5):352-65. doi: 10.1016/j.annpat.2014.08.018. Epub 2014 Sep 26. French. PMID: 25439988

9.

Guiu S, Wolfer A, Jacot W, Fumoleau P, Romieu G, Bonnetain F, Fiche M.Crit

Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?

Rev Oncol Hematol. 2014 Dec;92(3):235-57. doi: 10.1016/j.critrevonc.2014.07.003. Epub 2014 Jul 30.PMID: 25129506